Skip to main content
Back
Watch Compare

Cytosorbents Corp

Data quality: 83%
CTSO
Nasdaq Manufacturing Measuring & Analyzing Instruments
$0.61
▲ $0.01 (0.84%)
Mkt Cap: 38.31 M
Price
$0.61
Mkt Cap
38.31 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -12.54 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-79.57%
Below sector avg (-53.53%)
ROIC-31.58%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
1.61
Above sector avg (0.31)
Current Ratio2.11
Interest CoverageN/A

Valuation

PE (TTM)
-4.67
Below sector avg (-1.48)
P/B Ratio4.25
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1366 peers)
Metric Stock Sector Median
P/E -4.7 -1.5
P/B 4.3 1.6
ROE % -79.6 -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 1.6 0.3

Analyst Price Target

3 analysts
Buy
Current
$0.61
+760.7%
Target
$5.25
$0.75
$5.00
$10.00
Forecast
Forward EPS $0.00
Est. Revenue 49.08 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 $0.00
$0.00 – $0.00
 49.08 M 1
FY2026 -$0.18
-$0.19 – -$0.16
 40.09 M 3

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.05 -$0.09 -80.0%
Q32025 -$0.05 -$0.05 -7.1%
Q22025 -$0.06 $0.03 +152.9%
Q12025 -$0.07 -$0.02 +71.4%

ETFs Holding This Stock

CFSSX CFSSX
0.00% weight
CFSLX CFSLX
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.20 M
ROE -79.57% ROA -17.49%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12.54 M
ROIC -31.58% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.61 Current Ratio 2.11
Interest Coverage N/A Asset Turnover N/A
Working Capital 11.20 M Tangible Book Value 5.43 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.67 Forward P/E N/A
P/B Ratio 4.25 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -32.74%
Market Cap 38.31 M Enterprise Value 45.34 M
Per Share
EPS (Diluted TTM) -0.13 Revenue / Share N/A
FCF / Share -0.20 OCF / Share -0.20
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 152.98%
SBC-Adj. FCF -15.20 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -8.20 M -20.72 M -28.51 M -32.81 M -24.56 M
EPS (Diluted) -0.13 -0.38 -0.64 -0.75 -0.57
Gross Profit 26.49 M 25.13 M 22.39 M 20.73 M 32.12 M
Operating Income -14.75 M -16.79 M -31.21 M -31.52 M -22.74 M
EBITDA — — — — —
R&D Expenses — — 15.73 M 15.12 M 16.38 M
SG&A Expenses 35.65 M 35.00 M 33.60 M 34.29 M 35.75 M
D&A 1.23 M 1.57 M 1.46 M 882,621.0 731,578.0
Interest Expense — — — — —
Income Tax -401,000.0 -1.69 M -813,739.0 -1.09 M -736,003.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 44.18 M 47.37 M 53.26 M 63.23 M 89.52 M
Total Liabilities 38.28 M 36.26 M 29.99 M 27.86 M 26.94 M
Shareholders' Equity 5.90 M 11.11 M 23.28 M 35.37 M 62.58 M
Total Debt 16.67 M 14.00 M 5.04 M 5.00 M —
Cash & Equivalents 6.25 M 3.28 M 14.13 M 22.14 M 52.14 M
Current Assets 20.63 M 21.60 M 25.70 M 33.76 M 64.30 M
Current Liabilities 9.71 M 9.82 M 14.55 M 9.71 M 13.69 M